Advances in Cell Membrane Biomimetic Nano-Delivery Systems for Brain Tumor Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Biomimetic nano-delivery systems (BNDS) are engineered using natural biological materials to overcome challenges in drug delivery.
• Cell membrane coatings on nanocarriers mimic endogenous cell properties for improved therapeutic efficacy.
• Targeting brain tumors requires overcoming physiological barriers like the blood-brain barrier (BBB) and blood-tumor barrier (BTB).

Purpose of the Study:

• To review the design, targeting mechanisms, and therapeutic potential of cell membrane-based nano-delivery systems for brain tumor therapy.
• To highlight the advantages of biomimetic systems in overcoming biological barriers and achieving targeted drug delivery.
• To summarize recent research progress and applications of these systems in preclinical and clinical settings.

Main Methods:

• Construction of BNDS using various cell membranes (erythrocytes, immune cells, tumor cells, stem cells, platelets) hybridized with nanocarriers.
• Analysis of targeting mechanisms, including passive and active targeting strategies across the BBB/BTB.
• Evaluation of therapeutic payload delivery (small molecules, nucleic acids, proteins) and treatment responses in brain tumor models.

Main Results:

• BNDS successfully cross the BBB/BTB, delivering therapeutic agents to brain tumor tissues.
• Cell membrane coatings provide unique targeting, barrier transport, and immunomodulatory advantages.
• These systems demonstrate tunable responses to stimuli like photothermal effects, enzymes, and pH for controlled drug release.

Conclusions:

• Cell membrane-derived BNDS represent a promising strategy for advanced brain tumor therapy.
• The biomimetic approach enhances drug delivery efficiency and therapeutic outcomes.
• Further research into optimizing BNDS construction and clinical translation is warranted.